**Study Summary**: This study is testing a medicine called **ribupatide** to see if it helps people lose weight. **Ribupatide** is given as a weekly shot under the skin, called a subcutaneous (SC) injection. People in the study will either get ribupatide or a placebo (a shot without medicine) to compare the effects on body weight. **Placebo** is used to see if changes happen because of the real medicine or not. To join, you need a **BMI** (Body Mass Index) of 30 or more, or 27 with a weight-related condition like high blood pressure, bad cholesterol levels, sleep troubles, or heart disease. You should have tried but not succeeded in losing weight with diet or exercise in the last six months. You cannot join if you have diabetes or have been on certain weight-changing medicines recently. **Key Points**: - **Length of Study**: Weekly injections are given. - **Compensation**: Information not provided. - **Risks**: Excludes those with certain health conditions like diabetes or unstable heart disease. **HTML Tags**:html

This study is testing a medicine called ribupatide to see if it helps people lose weight. Ribupatide is given as a weekly shot under the skin, called a subcutaneous (SC) injection. People in the study will either get ribupatide or a placebo (a shot without medicine) to compare the effects on body weight. Placebo is used to see if changes happen because of the real medicine or not.

To join, you need a BMI (Body Mass Index) of 30 or more, or 27 with a weight-related condition like high blood pressure, bad cholesterol levels, sleep troubles, or heart disease. You should have tried but not succeeded in losing weight with diet or exercise in the last six months. You cannot join if you have diabetes or have been on certain weight-changing medicines recently.

• Length of Study: Weekly injections are given.
• Compensation: Information not provided.
• Risks: Excludes those with certain health conditions like diabetes or unstable heart disease.